Dr. Honesto M. Poblete, MD

Dr. Poblete practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Poblete's NPI, 1972761799, was assigned on May 29, 2008. Dr. Poblete holds New Jersey license 25MA08589100.

Dr. Poblete's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Poblete's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Poblete is also affiliated with Robert Wood Johnson University Hospital Hamilton. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Poblete to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poblete practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Poblete's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Poblete's licenses on file in 3 states: New Jersey, New York and Pennsylvania.

CMS data shows 1,456 Medicare services from Dr. Poblete across 14 procedure codes in 2024, for 440 Medicare patients. Medicare paid $111,507 for them.

CMS counts 440 Medicare patients who saw Dr. Poblete in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poblete's median patient age at 74, with 45% women.

In 2024, Dr. Poblete wrote 517 Medicare Part D claims for 178 patients. 63% of them were for generic drugs. CMS names the drug for 453 of them, across 11 drugs with 11 or more claims each, at $170,891 in total drug cost. In 2023, CMS named 424 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Poblete for performance year 2024, reported through an alternative payment model (APM). Dr. Poblete accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poblete as offering telehealth. CMS counts 25 procedures of leg revascularization (restoring blood flow) by Dr. Poblete, more than 85% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 109 general payments to Dr. Poblete from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $8,000. It also lists 2 research payments totaling $3,000 in 2024.